DSM Integrated Annual Report 2022

Profit at a glance

+15%

Sales from continuing operations

versus 2021, with organic sales +8% in Health, Nutrition & Bioscience

+1%

Adjusted EBITDA from continuing operations

versus 2021, with Health, Nutrition & Bioscience +2%

€310

Adjusted net operating free cash flow from continuing operations,

-50% versus 2021

€555

million Adjusted Net profit from continuing operations,

-3% versus 2021